$14.45
In chiusura: Sep 29, 9:05 AM EDT
$13.50
-0.95-6.57%
Pre-mercato: Sep 29, 9:05 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Atara Biotherapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-0.730
Stima dei ricavi trimestrali
$2.16M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$188.67M
Analizza lo storico degli utili di Atara Biotherapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ATRA | Atara Biotherapeutics | -$2.93 | -$0.73 | — | — | $40.19M | $2.16M | — | — | 11/11/2025 | |
ATRA | Atara Biotherapeutics | -$3.10 | -$0.32 | $0.19 | 159.38% | $28.64M | $5.57M | $17.57M | 215.72% | 08/11/2025 | |
ATRA | Atara Biotherapeutics | -$5.75 | -$1.92 | $3.50 | 282.29% | $27.36M | $4.30M | $98.15M | 2182.53% | 05/15/2025 | |
ATRA | Atara Biotherapeutics | -$14.00 | -$2.48 | -$1.19 | 52.02% | $4.25M | $24.75M | $32.75M | 32.34% | 03/07/2025 | |
ATRA | Atara Biotherapeutics | -$16.50 | -$1.93 | -$2.93 | -51.81% | $2.14M | $35.17M | $40.19M | 14.27% | 11/12/2024 | |
ATRA | Atara Biotherapeutics | -$17.00 | -$1.56 | -$3.10 | -98.72% | $957.00K | $39.99M | $28.64M | -28.38% | 08/12/2024 | |
ATRA | Atara Biotherapeutics | -$18.00 | -$6.50 | -$5.75 | 11.54% | $1.23M | $24.69M | $27.36M | 10.80% | 05/09/2024 | |
ATRA | Atara Biotherapeutics | -$18.00 | -$12.00 | -$14.00 | -16.67% | $221.00K | $11.55M | $4.25M | -63.19% | 03/28/2024 | |
ATRA | Atara Biotherapeutics | -$20.50 | -$16.50 | -$16.50 | 0.00% | $4.46M | $4.76M | $2.14M | -55.08% | 11/01/2023 | |
ATRA | Atara Biotherapeutics | -$7.75 | -$16.75 | -$17.00 | -1.49% | $51.58M | $3.77M | $957.00K | -74.62% | 08/08/2023 | |
ATRA | Atara Biotherapeutics | -$21.75 | -$9.75 | -$18.00 | -84.62% | $7.31M | $30.68M | $1.23M | -96.00% | 05/08/2023 | |
ATRA | Atara Biotherapeutics | -$24.00 | -$12.75 | -$18.00 | -41.18% | $7.55M | $39.67M | $221.00K | -99.44% | 02/08/2023 | |
ATRA | Atara Biotherapeutics | -$22.50 | -$19.50 | -$20.50 | -5.13% | $5.37M | $5.27M | $4.46M | -15.39% | 11/08/2022 | |
ATRA | Atara Biotherapeutics | -$22.75 | -$23.25 | -$7.75 | 66.67% | $3.87M | $6.84M | $51.58M | 654.08% | 08/08/2022 | |
ATRA | Atara Biotherapeutics | -$21.50 | -$24.50 | -$21.75 | 11.22% | $3.55M | $4.91M | $7.31M | 48.96% | 05/05/2022 | |
ATRA | Atara Biotherapeutics | -$23.75 | -$17.25 | -$24.00 | -39.13% | $0.00 | $35.14M | $7.55M | -78.52% | 02/28/2022 | |
ATRA | Atara Biotherapeutics | -$23.00 | -$23.50 | -$22.50 | 4.26% | $0.00 | $3.92M | $5.37M | 36.99% | 11/04/2021 | |
ATRA | Atara Biotherapeutics | -$28.50 | -$22.25 | -$22.75 | -2.25% | $0.00 | $3.84M | $3.87M | 0.78% | 08/09/2021 | |
ATRA | Atara Biotherapeutics | -$30.00 | -$23.00 | -$21.50 | 6.52% | $0.00 | $1.60M | $3.55M | 122.00% | 05/04/2021 | |
ATRA | Atara Biotherapeutics | -$34.00 | -$18.50 | -$23.75 | -28.38% | $0.00 | $13.33M | $0.00 | -100.00% | 03/01/2021 | |
ATRA | Atara Biotherapeutics | -$32.75 | -$27.25 | -$23.00 | 15.60% | $0.00 | — | $0.00 | — | 11/09/2020 |
Atara Biotherapeutics (ATRA) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $0.19 | $-0.32 | 159.4 % |
| Q1 | 2025-05-15 | $3.50 | $-1.92 | 282.3 % |
| Q4 | 2025-03-07 | $-1.19 | $-2.48 | 52.0 % |
| Q3 | 2024-11-12 | $-2.93 | $-1.93 | -51.8 % |
Atara Biotherapeutics (ATRA) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $17.58M | $5.57M | 215.7 % |
| Q1 | 2025-05-15 | $98.15M | $4.30M | 2182.5 % |
| Q4 | 2025-03-07 | $32.75M | $24.75M | 32.3 % |
| Q3 | 2024-11-12 | $40.19M | $35.17M | 14.3 % |
FAQ
Quando Atara Biotherapeutics (NASDAQ:ATRA) riporterà gli utili?
Si prevede che Atara Biotherapeutics (ATRA) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Atara Biotherapeutics (NASDAQ:ATRA)?
L'EPS effettivo era $0.19, che superato la stima di $-0.32.
Quali sono state le entrate di Atara Biotherapeutics (NASDAQ:ATRA)?
Le entrate effettive sono state $17.6M, che superato la stima di $5.6M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.